October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- Wyden to USTR: Congress Must Approve Binding Trade Deals
- Wyden, Warren, Gillibrand, and Sanders Demand Answers on Reckless Rollout of AI Tools at Social Security
- Wyden Condemns Passage of Cruel Senate Republican Budget
- Wyden Opposes Trump and Senate Republicans' Big Bad Bill Ahead of the Vote
- Wyden Blasts Budget Fakery as Republicans Go Nuclear